Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. 1998

T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
Department of Neurosurgery, Miyazaki Medical College, Japan. nstm@post.miyazaki-med.ac.jp

Recent findings suggest that hepatocyte growth factor/scatter factor (HGF/SF) contributes to the malignant progression of human gliomas. We investigated the effect of HGF/SF on vascular endothelial growth factor (VEGF) expression of c-Met/HGF receptor-positive human glioma cell lines. Treatment of the glioma cells with various concentrations of HGF/SF resulted in an enhanced secretion of VEGF proteins accompanying increased transcription of VEGF mRNA in a dose-dependent fashion. Since malignant gliomas frequently co-express HGF/SF and its receptor, these results suggest that HGF/SF could act as an indirect angiogenic factor through autocrine induction of VEGF expression and secretion in malignant gliomas.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D016228 Endothelial Growth Factors These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences. Endothelial Cell-Derived Growth Factors,alpha-Endothelial Growth Factor,beta-Endothelial Growth Factor,ECDGF,Endo-GF,Endothelial Growth Factor,Endothelial Growth Factor Polypeptides,Endothelial Cell Derived Growth Factors,Growth Factor, Endothelial,Growth Factor, alpha-Endothelial,Growth Factor, beta-Endothelial,Growth Factors, Endothelial,alpha Endothelial Growth Factor,beta Endothelial Growth Factor
D017228 Hepatocyte Growth Factor Multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is PROTO-ONCOGENE PROTEINS C-MET. Hepatopoietin,Hepatopoietin A,Scatter Factor,Factor, Hepatocyte Growth,Factor, Scatter,Growth Factor, Hepatocyte
D042442 Vascular Endothelial Growth Factors A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells. VEGFs
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular

Related Publications

T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
October 2001, Biology of reproduction,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
January 2003, Arteriosclerosis, thrombosis, and vascular biology,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
January 1993, Cell biology international,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
February 2004, Biochimica et biophysica acta,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
May 1994, Proceedings of the National Academy of Sciences of the United States of America,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
March 2001, Clinical cancer research : an official journal of the American Association for Cancer Research,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
May 1999, Neurosurgery,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
October 2003, Biochemical and biophysical research communications,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
March 1999, International journal of cancer,
T Moriyama, and H Kataoka, and R Hamasuna, and K Yokogami, and H Uehara, and H Kawano, and T Goya, and H Tsubouchi, and M Koono, and S Wakisaka
April 2003, Cancer research,
Copied contents to your clipboard!